In transgenic mice, over-expression of PLP1 produces myelin defects similar to those observed in PMD patients, as well as the accumulation of PLP in vacuoles of the oligodendrocyte soma [25]. The gene discussed is PLP1; the disease is Pelizeaus-Merzbacher spectrum disorder.